Managing the significant drug‐drug interaction between isavuconazole and tacrolimus in solid organ transplant recipients

Documenti analoghi

• Contemporary Immunosuppression Management and 1‐Year Outcomes in Dual Organ Heart Transplantation
  di: Xinyi Huang, et al.
  Pubblicazione: (2024)
• Tixagevimab/cilgavimab for the prevention of COVID‐19 in solid organ transplant recipients
  di: Emily Eribes, et al.
  Pubblicazione: (2024)
• Cardiovascular outcomes in solid organ transplant recipients undergoing cardiac surgery: A matched pair analysis
  di: Kitae Kim, et al.
  Pubblicazione: (2024)
• Letter to the editor: Poor sensitivity of anti‐nucleocapsid antibody in detecting prior COVID‐19 in vaccinated solid organ transplant recipients
  di: Jennifer L. Alejo, et al.
  Pubblicazione: (2024)
• Prevalence of iron deficiency and anemia in pediatric heart transplant recipients
  di: David M. Newland, et al.
  Pubblicazione: (2024)